Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
KRAS mutation
Description:
A KRAS mutation is a genetic alteration in the KRAS gene, studied in cancer for its role in tumor development and treatment response.
Related topics:
Colorectal Cancer Treatments and Studies (16%),
Lung Cancer Treatments and Mutations (15%),
Pancreatic and Hepatic Oncology Research (11%)
Wikidata ID:
wiki/Q28445037
OpenAlex ID:
keywords/kras-mutation
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
2014
·
Chetan Bettegowda
, Mark Sausen
, et al.
·
Science Translational Medicine
·
5,252
Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain
2005
·
William Pao
, Vincent A Miller
, et al.
·
PLoS Medicine
·
3,588
PDF
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008
·
Rafael G. Amado
, Michael Wolf
, et al.
·
Journal of Clinical Oncology
·
3,274
PDF
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015
·
Sonia A. Melo
, Linda B. Luecke
, et al.
·
Nature
·
3,001
Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review
2021
·
Leah H. Biller
, Deborah Schrag
·
JAMA
·
2,876
Clues to the Pathogenesis of Familial Colorectal Cancer
1993
·
Lauri A. Aaltonen
, Päivi Peltomäki
, et al.
·
Science
·
2,713
Pancreatic cancer
2016
·
Terumi Kamisawa
, Laura D Wood
, et al.
·
The Lancet
·
2,488
Pancreatic Adenocarcinoma
2014
·
David P. Ryan
, Theodore S. Hong
, et al.
·
New England Journal of Medicine
·
2,447
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
2005
·
H. Shigematsu
, L. Lin
, et al.
·
JNCI Journal of the National Cancer Institute
·
2,411
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
2006
·
Astrid Lièvre
, Jean-Baptiste Bachet
, et al.
·
Cancer Research
·
2,274
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
2010
·
Wendy De Roock
, Bart Claes
, et al.
·
The Lancet Oncology
·
2,206
Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma
2017
·
Benjamin J. Raphael
, Ralph H. Hruban
, et al.
·
Cancer Cell
·
2,146
PDF
Pancreatic cancer
2016
·
Jorg Kleeff
, Murray Korc
, et al.
·
Nature Reviews Disease Primers
·
2,099
PDF
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
2014
·
Thomas F. Imperiale
, David F. Ransohoff
, et al.
·
New England Journal of Medicine
·
1,991
PDF
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
2012
·
Sandra Misale
, Rona Yaeger
, et al.
·
Nature
·
1,970
Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
2011
·
Eric Van Cutsem
, Claus-Henning Köhne
, et al.
·
Journal of Clinical Oncology
·
1,932
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
2010
·
Poulikos I. Poulikakos
, Chao Zhang
, et al.
·
Nature
·
1,851
PDF
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
2012
·
Luis A. Diaz Jr
, Richard T. Williams
, et al.
·
Nature
·
1,780
RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
2007
·
Nicholas Yagoda
, Moritz von Rechenberg
, et al.
·
Nature
·
1,680
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
2010
·
Georgia Hatzivassiliou
, Kyung Song
, et al.
·
Nature
·
1,659
Integrated genomic and molecular characterization of cervical cancer
2017
·
Robert D. Burk
, Zigui Chen
, et al.
·
Nature
·
1,651
PDF
Wild-Type BRAF Is Required for Response to Panitumumab or Cetuximab in Metastatic Colorectal Cancer
2008
·
Federica Di Nicolantonio
, Miriam Martini
, et al.
·
Journal of Clinical Oncology
·
1,623
PDF
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value
2013
·
Laetitia Marisa
, Aurélien de Reyniès
, et al.
·
PLoS Medicine
·
1,600
PDF
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
2005
·
William Pao
, Theresa Y Wang
, et al.
·
PLoS Medicine
·
1,550
PDF
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
2003
·
Sarah P. Thayer
, Marina Pasca di Magliano
, et al.
·
Nature
·
1,498
Show more works
View as search
Works count:
29,320
Citation count:
738,700
Year
Topic
Type